A consent form can satisfy disclosure requirements while leaving the patient unprepared for the decisions, procedures, and burden that follow.
The direct answer
Health literacy in clinical trials is the ability to find, understand, evaluate, and use study information in context. It is not a fixed patient trait. Trial complexity, stress, language, format, timing, and cognitive load can make anyone less able to use information.
Health literacy is situational.
People who manage complex careers and healthcare decisions can still struggle when they receive unfamiliar scientific information during illness. Working memory is limited, stress narrows attention, and long documents make it difficult to identify what matters most.
The problem is not simply reading level. Patients must translate information into action: where to go, what to stop taking, what symptoms to report, how long participation lasts, and what the experience may require from family or work.
Disclosure is not the same as comprehension.
Research on informed consent has repeatedly found that understanding varies across critical concepts such as randomization, placebo, risks, alternatives, and the voluntary nature of participation. Longer or more detailed documents do not reliably solve that problem.
Education should therefore begin before consent, continue during deliberation, and remain available after enrollment. The question is not whether information was delivered. It is whether the patient can use it.
Readiness education reduces cognitive work.
- Layer information from essential to detailed.
- Use plain language without removing scientific accuracy.
- Combine text with visual, audio, and conversational formats.
- Translate procedures into a timeline patients can imagine.
- Use teach-back to uncover misunderstanding.
- Prepare caregivers for the decisions and tasks they may share.
- Update only what changed after an amendment.
This is the operating logic behind CORE: education is designed around the friction that can interrupt participation, not around a catalog of materials.
Comprehension should be monitored over time.
Understanding can decay as the trial changes or new burdens emerge. A patient may understand randomization at consent but become uncertain when treatment begins. A caregiver may understand visit frequency but not the cumulative effect on work and travel.
Readiness education treats comprehension as dynamic. It reinforces what matters when it matters, creating a more stable foundation for informed participation.
Sources.
- National Academies, Health Literacy in Clinical Research
- Flory and Emanuel, Interventions to improve informed-consent understanding
- Tam et al., Participants' understanding of informed consent
- FDA, Informed Consent Guidance
